grade
analytical standard
drug control
Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland
concentration
1.0 mg/mL in methanol
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
single component solution
storage temp.
2-8°C
SMILES string
CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)c3ccccc3)C(O)=O
InChI
1S/C16H19NO4/c1-17-11-7-8-12(17)14(15(18)19)13(9-11)21-16(20)10-5-3-2-4-6-10/h2-6,11-14H,7-9H2,1H3,(H,18,19)/t11-,12+,13-,14+/m0/s1
InChI key
GVGYEFKIHJTNQZ-RFQIPJPRSA-N
Gene Information
rat ... Slc6a3(24898)
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Still not finding the right product?
Explore all of our products under 苯甲酰芽子碱标准液 溶液
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
存储类别
3 - Flammable liquids
wgk
WGK 1
flash_point_f
51.8 °F - closed cup
flash_point_c
11 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves
法规信息
新产品
此项目有
N Nikolettos et al.
Clinical and experimental obstetrics & gynecology, 39(1), 36-42 (2012-06-09)
To investigate the response of pregnant and non pregnant rat myometrium to benzoylecgonine, a cocaine metabolite, and oxytocin and to investigate the efficiency of ritodrine and atosiban to overcome the effects of benzoylecgonine and oxytocin. Isolation of rat myometrial tissue
Beata Bystrowska et al.
Pharmacological reports : PR, 64(6), 1337-1349 (2013-02-15)
We employed a cocaine intravenous self-administration model based on positive reinforcement of animals' instrumental reactions (i.e., lever pressing) rewarded by a dose of the drug. We also carried out simultaneous characterization of the pharmacokinetics of cocaine and its metabolites in
Charles A Dackis et al.
Journal of substance abuse treatment, 43(3), 303-312 (2012-03-02)
This is a randomized, double-blind, placebo-controlled study of modafinil treatment for cocaine dependence. Patients (N = 210) who were actively using cocaine at baseline were randomized to 8 weeks of modafinil (0 mg/day, 200 mg/day, or 400 mg/day) combined with